# Genomic and epigenomic predictors of response to guadecitabine in relapsed/refractory acute myelogenous leukemia

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/genomic-and-epigenomic-predictors-of-response-to-guadecitabine-in-relapsed/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Woonbok Chung,Andrew D. Kelly,Patricia Kropf,Henry C. Fung,Jaroslav Jelı́nek,Xiang Yao Su,Gail J. Roboz,Hagop M. Kantarjian,Mohammad Azab,Jean‐Pierre J. Issa |
| Citations | 29 |
| DOI | 10.1186/s13148-019-0704-3 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://link.springer.com/content/pdf/10.1186/s13148-019-0704-3.pdf |
| OpenAlex ID | https://openalex.org/W2963483321 |
| PMID | 31331399 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Xiang Yao Su](https://scholariq.org/researchers/xiang-yao-su/)

## Paper primary topic

- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)

## Paper topics

- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)
- [Epigenetics and DNA Methylation](https://scholariq.org/topics/epigenetics-and-dna-methylation/)
- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.